Health Condition 1: E79- Disorders of purine and pyrimidinemetabolism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants of age group 18-59 year Male with SUA level more than 7 mg/dl and female with more than 6.0 mg/dl Participants willing to give consent will be included Uric acid diathesis as Eliminating Rubric
Exclusion criteria
Exclusion criteria: Participants with unstable mental or psychiatric diseases, uncontrolled or severe systemic illnesses, substance abuse, severe endocrine disorders, and already receiving homeopathic treatment for any chronic condition for past 3 months Pregnant and lactating females Recurrent case of renal stone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that there will be reduction in serum uric acid level of patients. There will be improvement in patient’s outcome without any substantial medical adverse effect hence a significant reduction in serum uric acid level is expected as compared to baseline and at 6 months. Timepoint: 15 months study Enrollment – 6 months follow up – 6 months Statistical analysis – 3 months first dose after case taking subsequent doses as per follow ups | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: Not Applicable | — |
Countries
India
Contacts
Bakson Homoeopathic Medical College and Hospital